Colfax (NYSE: CFX ) is expected to report Q1 earnings on April 25. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Colfax's revenues will grow 8.1% and EPS will grow 4.3%.
The average estimate for revenue is $958.6 million. On the bottom line, the average EPS estimate is $0.24.
Last quarter, Colfax reported revenue of $1.03 billion. GAAP reported sales were much higher than the prior-year quarter's $177.8 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.42. GAAP EPS were $0.14 for Q4 against -$0.37 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 31.8%, 280 basis points worse than the prior-year quarter. Operating margin was 9.0%, 350 basis points worse than the prior-year quarter. Net margin was 1.9%, much better than the prior-year quarter.
The full year's average estimate for revenue is $4.21 billion. The average EPS estimate is $1.85.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 270 members out of 285 rating the stock outperform, and 15 members rating it underperform. Among 67 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 64 give Colfax a green thumbs-up, and three give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Colfax is hold, with an average price target of $37.63.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Colfax to My Watchlist.